Arcus Biosciences (RCUS) Net Income: 2017-2025
Historic Net Income for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -$135.0 million.
- Arcus Biosciences' Net Income fell 46.74% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$433.0 million, marking a year-over-year decrease of 60.37%. This contributed to the annual value of -$283.0 million for FY2024, which is 7.82% up from last year.
- Per Arcus Biosciences' latest filing, its Net Income stood at -$135.0 million for Q3 2025, which was down 20.54% from -$112.0 million recorded in Q1 2025.
- In the past 5 years, Arcus Biosciences' Net Income registered a high of $279.5 million during Q4 2021, and its lowest value of -$135.0 million during Q3 2025.
- For the 3-year period, Arcus Biosciences' Net Income averaged around -$83.7 million, with its median value being -$86.5 million (2023).
- Within the past 5 years, the most significant YoY rise in Arcus Biosciences' Net Income was 637.62% (2021), while the steepest drop was 4,379.64% (2021).
- Over the past 5 years, Arcus Biosciences' Net Income (Quarterly) stood at $279.5 million in 2021, then plummeted by 123.97% to -$67.0 million in 2022, then decreased by 20.90% to -$81.0 million in 2023, then fell by 16.05% to -$94.0 million in 2024, then crashed by 46.74% to -$135.0 million in 2025.
- Its last three reported values are -$135.0 million in Q3 2025, -$112.0 million for Q1 2025, and -$94.0 million during Q4 2024.